NZ545470A - Lipid system and methods of use - Google Patents

Lipid system and methods of use

Info

Publication number
NZ545470A
NZ545470A NZ545470A NZ54547004A NZ545470A NZ 545470 A NZ545470 A NZ 545470A NZ 545470 A NZ545470 A NZ 545470A NZ 54547004 A NZ54547004 A NZ 54547004A NZ 545470 A NZ545470 A NZ 545470A
Authority
NZ
New Zealand
Prior art keywords
omega
fatty acids
acid
composition
ratio
Prior art date
Application number
NZ545470A
Other languages
English (en)
Inventor
Vikkie A Mustad
Stephen Demichele
Bradley A Zinker
Yung-Sheng Huang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NZ545470A publication Critical patent/NZ545470A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
NZ545470A 2003-09-05 2004-08-04 Lipid system and methods of use NZ545470A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/656,662 US7759507B2 (en) 2003-09-05 2003-09-05 Lipid system and methods of use
PCT/US2004/025161 WO2005025334A1 (en) 2003-09-05 2004-08-04 Lipid system and methods of use

Publications (1)

Publication Number Publication Date
NZ545470A true NZ545470A (en) 2009-06-26

Family

ID=34226392

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ545470A NZ545470A (en) 2003-09-05 2004-08-04 Lipid system and methods of use

Country Status (13)

Country Link
US (2) US7759507B2 (cg-RX-API-DMAC7.html)
EP (1) EP1662905A1 (cg-RX-API-DMAC7.html)
JP (1) JP5745734B2 (cg-RX-API-DMAC7.html)
KR (1) KR20060076766A (cg-RX-API-DMAC7.html)
CN (1) CN1874692B (cg-RX-API-DMAC7.html)
AU (2) AU2004271928B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0414096A (cg-RX-API-DMAC7.html)
CA (1) CA2536692C (cg-RX-API-DMAC7.html)
IL (1) IL173967A (cg-RX-API-DMAC7.html)
MX (1) MXPA06002481A (cg-RX-API-DMAC7.html)
NZ (1) NZ545470A (cg-RX-API-DMAC7.html)
WO (1) WO2005025334A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200602768B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344747B2 (en) * 2004-04-29 2008-03-18 Gfa Brands, Inc. Oxidative stabilization of omega-3 fatty acids in low linoleic acid-containing peanut butter
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
BRPI0614417A2 (pt) * 2005-07-28 2011-03-29 Reliant Pharmaceuticals Inc composições farmacêuticas compreendendo bloqueadores de canais de cálcio de dihidropiridina e ácidos graxos de Èmega-3 e métodos de tratamento utilizando as mesmas
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
JP5158715B2 (ja) * 2006-05-16 2013-03-06 独立行政法人産業技術総合研究所 平滑筋収縮抑制剤
US20110111112A1 (en) * 2006-12-28 2011-05-12 The Nisshin Oillio Group, Ltd. Oil-and-fat composition, and food or beverage containing the oil-and-fat composition
WO2008085019A1 (en) * 2007-01-11 2008-07-17 Carotino Sdn. Bhd. A method for lowering risk of cardiovascular diseases
WO2008103926A1 (en) * 2007-02-22 2008-08-28 Innlabs, Llc Vitamin c preparation
US20080269328A1 (en) * 2007-04-09 2008-10-30 Mohammed Moghadasian Effects of low n-6:n-3 fatty acid ratio from two dietary sources on plasma and tissue lipid composition
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US20100010088A1 (en) * 2007-11-01 2010-01-14 Wake Forest University School Of Medicine Compositions and Methods for Prevention and Treatment of Mammalian Diseases
US20090155447A1 (en) * 2007-12-12 2009-06-18 Solae, Llc Protein extrudates comprising omega-3 fatty acids
US20110177224A1 (en) * 2008-03-03 2011-07-21 Daniel Perlman Stabilization of omega-3 fatty acids in oil-water emulsions
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
WO2010040012A1 (en) * 2008-10-01 2010-04-08 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
JP5407362B2 (ja) * 2009-01-26 2014-02-05 株式会社カネカ 水中油型乳化油脂組成物
MX2011010229A (es) * 2009-04-01 2011-10-11 Nestec Sa Reduccion del riesgo de obesidad.
US20100272875A1 (en) * 2009-04-24 2010-10-28 Monsanto Technology Llc Omega-3 enriched cereal, granola, and snack bars
JP2009219500A (ja) * 2009-06-22 2009-10-01 Suntory Holdings Ltd 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US11986508B1 (en) 2010-04-06 2024-05-21 Juliana Konzny Nutritional and cosmetic product, system and method for use
CN101843336A (zh) * 2010-04-22 2010-09-29 王京南 亚麻油脂肪乳口服溶液、饮料及制造方法
JP6034805B2 (ja) 2011-02-02 2016-11-30 ネステク ソシエテ アノニム 高タンパク質栄養組成物並びにその製造方法及び使用方法
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2012145119A2 (en) * 2011-04-17 2012-10-26 Michael Gurin Low inflammatory blended oils
US10653160B2 (en) 2011-04-17 2020-05-19 Omega Foods, LLC Prepared foods having high efficacy omega 6/omega 3 balanced polyunsaturated fatty acids
WO2012145339A2 (en) * 2011-04-17 2012-10-26 Enviva Foods, Llc Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US10682327B2 (en) 2011-04-17 2020-06-16 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US8551551B2 (en) 2012-01-06 2013-10-08 Perlman Consulting, Llc Stabilization of omega-3 fatty acids in saturated fat microparticles having low linoleic acid content
SMT201800519T1 (it) 2012-01-06 2018-11-09 Omthera Pharmaceuticals Inc Composizioni di acidi grassi polinsaturi omega-3 in forma di acido libero arricchite in dpa
US20130295173A1 (en) 2012-05-07 2013-11-07 Omthera Pharmaceuticals, Inc. Compositions of statins and omega-3 fatty acids
WO2013186233A1 (en) * 2012-06-12 2013-12-19 Norwegian University Of Science And Technology Composition
EP2879523B1 (en) 2012-07-31 2016-11-16 Nestec S.A. Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (ibd)
CN104247787A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合普健康经济型a级双合食用油
CN104247786A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合健康双合食用油
CN104413167A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量35克以上人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413170A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量25-30克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413168A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量30-35克人群24种正营养食用油各种健康指标的脂肪酸科学配比
EP3190099B1 (de) 2015-09-14 2020-10-28 Helmholtz-Zentrum Potsdam - Deutsches GeoForschungsZentrum GFZ Stiftung des Öffentlichen Rechts des Lands Brandenburg Neue fettsäure und ihre verwendung
BR102016016559A2 (pt) * 2016-07-18 2018-02-06 Francisco Pianowski Luiz Apresentação de cloreto de magnésio ingerível
AU2023331991A1 (en) * 2022-09-01 2025-03-20 ETH Zürich Lipid emulsion with anti-inflammatory effects for total parenteral and enteral nutrition
CN116058417A (zh) * 2022-11-25 2023-05-05 新疆札郎孜生物科技有限公司 一种植物调和油及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4526902A (en) 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5059622A (en) 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB2223943A (en) 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
US5922345A (en) 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5308832A (en) 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
JPH0745616A (ja) * 1993-07-29 1995-02-14 Nec Corp 半導体装置の製造方法
ATE186174T1 (de) 1993-08-20 1999-11-15 Nestle Sa Lipidzusammensetzung für nahrungsmittel
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
DK0754001T3 (da) 1994-04-01 2002-05-13 Abbott Lab Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
DE4417851C1 (de) 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
JP3840670B2 (ja) 1995-01-27 2006-11-01 味の素株式会社 糖尿病患者用脂肪輸液剤
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5922704A (en) 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
JP2002516673A (ja) 1998-06-03 2002-06-11 ステート オブ イスラエル ミニストリー オブ アグリカルチャー アグリカルチャー リサーチ オーガニゼーション ザ ボルカニ センター マッティオラ種子油、これを含む混合物及びその利用
WO2000012179A1 (en) 1998-08-27 2000-03-09 Bowles Fluidics Corporation Water bottle with drinking and spray modes
JP3998355B2 (ja) * 1998-11-26 2007-10-24 日清オイリオグループ株式会社 食用油
AUPQ228199A0 (en) 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
JP4391673B2 (ja) * 2000-08-08 2009-12-24 花王株式会社 油脂組成物
CA2418350C (en) 2000-08-08 2010-01-19 Kao Corporation Oil/fat composition
US6432453B1 (en) 2000-08-26 2002-08-13 Metagenics, Inc. Dietary supplement containing glycerol ester of conjugated linoleic acid and rosemary extract containing carnosic acid
ES2223924T3 (es) * 2000-09-21 2005-03-01 Nutrition 21, Inc. Composiciones que contienen cromo para el tratamiento de la diabetes, la reduccion de la grasa corporal, la mejora de la sensibilidad a la insulina, la reduccion de la hiperglicemia y la reduccion de la hipercolesteremia.
DE10130491A1 (de) * 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
CN1339262A (zh) 2001-09-21 2002-03-13 阮生 食用香油

Also Published As

Publication number Publication date
EP1662905A1 (en) 2006-06-07
AU2011201489A1 (en) 2011-04-21
MXPA06002481A (es) 2006-06-20
KR20060076766A (ko) 2006-07-04
US20050054724A1 (en) 2005-03-10
IL173967A0 (en) 2006-07-05
CN1874692B (zh) 2011-10-19
CA2536692C (en) 2013-04-16
AU2004271928B2 (en) 2011-04-14
JP5745734B2 (ja) 2015-07-08
US20080039525A1 (en) 2008-02-14
IL173967A (en) 2012-04-30
US7601757B2 (en) 2009-10-13
WO2005025334A1 (en) 2005-03-24
BRPI0414096A (pt) 2006-10-31
CN1874692A (zh) 2006-12-06
ZA200602768B (en) 2007-09-26
CA2536692A1 (en) 2005-03-24
JP2007504225A (ja) 2007-03-01
US7759507B2 (en) 2010-07-20
AU2004271928A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
CA2536692C (en) Lipid system and methods of use
US8173160B2 (en) Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions
US6444700B1 (en) Product and method to reduce stress induced immune suppression
DE69935995T3 (de) Polyungesättigen fettsäuren nährungsergänzung
US5723446A (en) Enteral formulation designed for optimized nutrient absorption and wound healing
US20130078362A1 (en) Liquid nutritional compositions containing unsaturated fatty acids
JP2001526908A (ja) 脂肪ブレンド
IL186759A (en) Composite nutritional products
CA2758889A1 (en) High fiber nutritional emulsions
CA2758854A1 (en) High fiber nutritional emulsions for blood glucose control
CA2758908A1 (en) High fiber nutritional emulsions with glycerin
JPH04152861A (ja) 栄養補給用栄養組成物
JP2537645B2 (ja) 薬剤的活性を有する栄養組成物
JP3358386B2 (ja) 流動食品
EP1237424A1 (en) Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 04 AUG 2017 BY THOMSON REUTERS

Effective date: 20140619

LAPS Patent lapsed